Viruses replicate their genomes at exceptionally high mutation rates. Their
offspring evolve rapidly and therefore, are able to evade common immunolog
ical and chemical antiviral agents. In parallel, virus genomes cannot toler
ate a further increase in mutation rate: Experimental evidence exists that
even few additional mutations are sufficient for the extinction of a viral
population. A future antiviral strategy might therefore aim at increasing t
he error-producing capacity of viral replication enzymes. We employed the i
principles of directed evolution and developed a scheme for the stringent
positive selection of error-prone polymerase activity. A mutant T7 RNA poly
merase with a nucleotide substitution error rate at least 20-fold greater t
han that of the wild-type was selected. This enzyme synthesized highly hete
rogeneous RNA products in vitro or in vivo and also decreased the replicati
on efficiency of wildtype bacteriophage T7 during infection.